ME

MetLife IncNYSE MET Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

54.821

Mega

Exchange

XNYS - New York Stock Exchange, Inc

MET Stock Analysis

ME

Uncovered

MetLife Inc is uncovered by Eyestock quantitative analysis.

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-53.8 %

Overvalued

Market cap $B

54.821

Dividend yield

3.90 %

Shares outstanding

774.36 B

MetLife, Inc. provides insurance and financial services to individual and institutional customers. The company is headquartered in New York City, New York and currently employs 45,000 full-time employees. The company went IPO on 2000-04-05. The company operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); and MetLife Holdings. The U.S. segment offers a range of protection products and services, such as term life insurance, variable life insurance, universal life insurance, dental, disability, and accident and health insurance. The Asia segment offers products and services to both individuals and corporations, as well as to other institutions, and their respective employees. The Latin America segment offers a broad range of products to both individuals and corporations and other institutions, including local, state and federal governments. The EMEA segment offers life insurance, accident and health insurance, retirement and savings products, and credit insurance. The MetLife Holdings segment offers variable, universal, and long-term care insurance.

View Section: Eyestock Rating